347 related articles for article (PubMed ID: 24755988)
1. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
2. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.
Kristoffersen K; Villingshøj M; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2013 Jul; 14(7):625-37. PubMed ID: 23792644
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.
Stockhausen MT; Kristoffersen K; Stobbe L; Poulsen HS
Cancer Biol Ther; 2014 Feb; 15(2):216-24. PubMed ID: 24525857
[TBL] [Abstract][Full Text] [Related]
4. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
[TBL] [Abstract][Full Text] [Related]
5. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
6. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
[TBL] [Abstract][Full Text] [Related]
8. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.
Ying M; Wang S; Sang Y; Sun P; Lal B; Goodwin CR; Guerrero-Cazares H; Quinones-Hinojosa A; Laterra J; Xia S
Oncogene; 2011 Aug; 30(31):3454-67. PubMed ID: 21383690
[TBL] [Abstract][Full Text] [Related]
9. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
[TBL] [Abstract][Full Text] [Related]
10. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade.
Chu Q; Orr BA; Semenkow S; Bar EE; Eberhart CG
Clin Cancer Res; 2013 Jun; 19(12):3224-33. PubMed ID: 23630166
[TBL] [Abstract][Full Text] [Related]
11. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
[TBL] [Abstract][Full Text] [Related]
12. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.
Sun P; Xia S; Lal B; Shi X; Yang KS; Watkins PA; Laterra J
BMC Cancer; 2014 Jun; 14():401. PubMed ID: 24893952
[TBL] [Abstract][Full Text] [Related]
13. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway.
Wu J; Ji Z; Liu H; Liu Y; Han D; Shi C; Shi C; Wang C; Yang G; Chen X; Shen C; Li H; Bi Y; Zhang D; Zhao S
Toxicol Lett; 2013 Jun; 220(1):61-9. PubMed ID: 23542114
[TBL] [Abstract][Full Text] [Related]
16. POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling.
Li Q; Wang J; Ma X; Wang M; Zhou L
J Bioenerg Biomembr; 2021 Oct; 53(5):621-632. PubMed ID: 34251584
[TBL] [Abstract][Full Text] [Related]
17. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.
Sun P; Xia S; Lal B; Eberhart CG; Quinones-Hinojosa A; Maciaczyk J; Matsui W; Dimeco F; Piccirillo SM; Vescovi AL; Laterra J
Stem Cells; 2009 Jul; 27(7):1473-86. PubMed ID: 19544453
[TBL] [Abstract][Full Text] [Related]
18. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate.
Hovinga KE; Shimizu F; Wang R; Panagiotakos G; Van Der Heijden M; Moayedpardazi H; Correia AS; Soulet D; Major T; Menon J; Tabar V
Stem Cells; 2010 Jun; 28(6):1019-29. PubMed ID: 20506127
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]